The compounds identified here include high-affinity ligands of ACE2 and spike protein that are registered drugs, and a dye used in biomedical applications, that may be candidates for repurposing or as chemical scaffolds for drug development to generate entry blockers to prevent or cure COVID-19. This evidence concerns the gene ACE2 and COVID-19.